当院における尿路敗血症の臨床的検討—プロカルシトニンの有用性について一

摘要

We clinicaliy evaluated 355 patients with urinary tract infections (UTI), suspected of having urosepsis at Tane General Hospital, and determined the usefulness of the biomarker procalcitonin (PGT) as an aid in predicting urosepsis. Clinical and microbiological data were collected. The logistic regression analysis was used to determine the risk factors of urosepsis. Of 355 patients,169 patients (47.6%) were diagnosed with urosepsis. C-reactive protein (CRP) (OR 2.633, p く 0.001), PGT (OR 2.153, p = 0.003) and clinical diagnosis (calculous pyelonephritis OR 1.886, p 二 0.019, acute prostatitis OR 3. 614, p く 0.001) were established as the independent risk factors of urosepsis. Of169 patients with urosepsis, 43 patients (25.4%) were diagnosed with severe urosepsis.